We have located links that may give you full text access.
ENDOCRINE OUTCOMES OF TRANS-SPHENOIDAL SURGERY FOR PITUITARY APOPLEXY VERSUS ELECTIVE SURGERY FOR PITUITARY ADENOMA.
Endocrine Practice 2019 January 19
OBJECTIVE: To determine the rate of hormone replacement therapy (HRT) after transsphenoidal surgery (TSS) for pituitary apoplexy (PA) vs. elective resection of a null cell (NC) macroadenoma.
METHODS: A retrospective cohort study was performed. Data was collected on all consecutive patients who underwent TSS surgery from December 31, 2000 to December 31, 2016. Patients were split into two groups: 1) patients that presented with PA, and 2) patients that underwent elective TSS for NC macroadenoma. Postoperative pituitary function was determined by examining HRT, hormone lab values, and an evaluation by an endocrinologist for each patient. The odds ratio was calculated to determine if there was an association between PA and the need for HRT after surgery when compared to elective resection of a NC macroadenoma.
RESULTS: The need for HRT was significantly higher in surgery for PA compared to resection of a NC macroadenoma (14.7% vs. 2.9% OR = 5.690; 95% CI 1.439 to 22.500; p = 0.013).
CONCLUSION: There is an increased need for hormone replacement therapy after surgery in patients with PA versus patients undergoing elective resection of NC macroadenoma. Further studies are warranted to strengthen this data and help determine further predictors of the need for HRT.
METHODS: A retrospective cohort study was performed. Data was collected on all consecutive patients who underwent TSS surgery from December 31, 2000 to December 31, 2016. Patients were split into two groups: 1) patients that presented with PA, and 2) patients that underwent elective TSS for NC macroadenoma. Postoperative pituitary function was determined by examining HRT, hormone lab values, and an evaluation by an endocrinologist for each patient. The odds ratio was calculated to determine if there was an association between PA and the need for HRT after surgery when compared to elective resection of a NC macroadenoma.
RESULTS: The need for HRT was significantly higher in surgery for PA compared to resection of a NC macroadenoma (14.7% vs. 2.9% OR = 5.690; 95% CI 1.439 to 22.500; p = 0.013).
CONCLUSION: There is an increased need for hormone replacement therapy after surgery in patients with PA versus patients undergoing elective resection of NC macroadenoma. Further studies are warranted to strengthen this data and help determine further predictors of the need for HRT.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app